🔎 Trials Near Me

Beranda › Penyakit Kardiovaskular › Kansas › Kansas City

Uji klinis Penyakit Kardiovaskular di Kansas City, KS

14 studi untuk Penyakit Kardiovaskular mencari peserta di lokasi sekitar Kansas City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

ELEVATE-HFpEF Clinical Study

Menerima peserta
  • University of Kansas Medical Center, Kansas City
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06678841

Product Surveillance Registry

Menerima pesertaStudi observasional
  • Kansas City, Kansas City
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT01524276

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Menerima pesertaFase 3
  • Clinical Trial Site, Kansas City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07181109

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Menerima peserta
  • University of Kansas Medical Center, Kansas City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT03242642

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Menerima peserta
  • The University Of Kansas Medical Center, Kansas City
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06310031

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Menerima pesertaFase 3
  • University of Kansas Hospital, Kansas City
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07517263

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Menerima pesertaFase 2
  • Clinical Research Site, Kansas City
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07333183

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Menerima pesertaFase 4Sukarelawan sehat diterima
  • University of Kansas Medical Center, Kansas City
Usia 75 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT04262206

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Menerima pesertaFase 3
  • Research Site, Kansas City
  • Research Site, Kansas City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Menerima pesertaFase 3
  • University of Kansas Medical Center, Kansas City
Usia 50 hingga 105 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07136012

The Oxford Risk Factors And Non-Invasive Imaging Study

Menerima pesertaStudi observasional
  • Midwest Heart & Vascular Specialists LLC, Kansas City
  • St Luke's Hospital, Kansas City
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT05169333

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Menerima peserta
  • University of Kansas Medical Center (KUMC), Kansas City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Menerima peserta
  • Kansas University Medical Center, Kansas City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06526195

Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Menerima pesertaFase 1/2
  • University of Kansas Medical Center, Kansas City
Usia 35 hingga 65 · Semua jenis kelamin · Diperbarui 8 Jun 2025 · NCT04715022

Uji klinis Penyakit Kardiovaskular di kota lain

Studi lain di Kansas City

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.